Fact CheckerSign in

NCT06512623Completed

Cytokine Adsorption During Complex Cardiac Surgery: a Controlled Randomized Trial

Cytokine Adsorption During Complex Cardiac Surgery: the JACCS Controlled Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 23 Jan 2026

Brief summary (registry, in English)

This prospective single-centre randomized controlled trial aims at evaluating the safety and efficacy of hemoadsorption with HA-380® during cardio-pulmonary bypass in 40 patients undergoing complex cardiac surgery.

Status (registry)
Completed
Study type
Interventional
Enrollment
41 (actual)
First submitted
1 Jul 2024
Start date
27 Oct 2024
Primary completion date
18 Dec 2025
Lead sponsor
Centre Hospitalier Universitaire Vaudois
NCT number
NCT06512623

What you commit to

  • Study type: Interventional
  • Participants enrolled: 41
  • From 27 Oct 2024 to the primary completion date, 18 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Indication to receive hemoadsorption during CPB for drugs removal
  • Previous enrolment into the current study
  • Participation in another study with investigational drug within the 30 days preceding and during the present study

Other illness

  • Known allergy to heparin or heparin induced thrombocytopenia

Lab values

  • Severe thrombopenia (platelets count before surgery \< 20g/L)

Other

  • Women who are pregnant or breastfeeding
  • Off-pump procedure
  • Chronic immunosuppression
  • Patient who does not want to be informed of incidental findings
  • Participation in another conflicting research study

Who the study is looking for

  • Adults (≥18 years old at study inclusion)
  • Planned for one of the following cardiac surgical procedures: heart transplantation after L-VAD (left ventricular assist device) implantation, OR surgical repair of a type A aortic dissection, OR urgent (within a few days) or emergent (within 24 hours) procedure for acute infectious endocarditis, OR cardiac surgery likely to require \>180 min CPB time as estimated by the surgical team
  • Signed informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre Hospitalier Universitaire Vaudois
Coordinator of this site? Confirm its status
LausanneSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.